WADA confirms agenda for Pharmaceutical Conference
WADA has confirmed the agenda for the international pharmaceutical conference on doping in sport to be held in Paris on November 12.
‘The Pharmaceutical Industry and the Fight against Doping: New Partnerships for Clean Sport’ is co-organized by hosts the Ministry of Sports, Youth, Non Formal Education and Voluntary Organizations of France, the Council of Europe, UNESCO and WADA.
It will also feature representatives from the International Olympic Committee (IOC) International Federation of Pharmaceutical Manufacturers Association (IFPMA), the Biotechnology Industry Organization (BIO) and some of the leading pharmaceutical companies worldwide.
WADA can also confirm that there has been a change of venue and the Conference will now be held at:
French Parliament House:
Chaban-Delmas Building, Room Victor Hugo
101 rue de l’Université 75007, Paris
The Conference will run from 09:00 – 17:30 and consists of two sessions. The morning session will focus on the issue of doping in sport and the societal consequences it has for the pharmaceutical and health industries.
The second session in the afternoon has been designed to explore a framework in which anti-doping organizations, in particular WADA, and the pharmaceutical industry can work together to tackle the problem.
Provisional AGENDA
FIRST SESSION: The Pharmaceutical Industry and WADA: Uniting for Clean Sport
Opening
Ms Valérie Fourneyron, Minister of Sports, Youth, Non Formal Education and Voluntary Organisations, France
Hon. John Fahey, President, World Anti-Doping Agency (WADA)
Ms Maud De Boer-Buquicchio, Deputy Secretary General, Council of Europe
Mr Getachew Engida, Deputy Director General, UNESCO
Dr Jacques Rogge, President, International Olympic Committee (IOC)
Part 1: Societal and economic risks of doping
Mr David Howman, Director General, WADA
Mr Philippe Lamoureux, Director General, LEEM, and Council Member of the International Federation of Pharmaceutical
Manufacturers and Associations (IFPMA)
Part 2: Health industry and anti-doping authorities: what is at stake in the cooperation?
Prof. Arne Ljungqvist, Vice President, WADA
Ms Patricia Brunko, Head of Unit, Directorate General of Health and Consumers (DG SANCO), European Commission
Mr Philip Thomson, Senior Vice President, Global Communications, GlaxoSmithKline
Mr James C. Greenwood, President and CEO, Biotechnology Industry Organisation (BIO)
Part 3: Health industry and anti-doping authorities: past experiences and lessons learnt
Dr Olivier Rabin, Science Director, WADA
Dr Philippe Van Der Auwera, Global Head of Drug Safety, Roche
Close: The way forward
Hon. John Fahey, President, World Anti-Doping Agency (WADA)
-------
SECOND SESSION: Presentation of the operational framework to the parties concerned (public authorities and pharmaceutical firms) to ensure their effective involvement
Round table 1: From the political concept to raising awareness among those involved: what kind of network to build and how to include all the stakeholders?
Moderator: Prof. Arne Ljungqvist, WADA
Rapporteur: Ms Patricia Brunko, European Commission
Panelists:
Dr. Laetitia Bigger, Regulatory and Scientific Affairs Manager, IFPMA
Representative from LEEM (tbc)
Mr Andy Parkinson, Chief Executive, UK Anti-Doping
Mr Andrew Emmett, Managing Director, Science and Regulatory Affairs, US BIO
A representative of EMA (tbc)
Round table 2: What framework is needed for co-operation between the World Anti-Doping Agency and stakeholders in the health sector? Lessons learnt: from raising awareness to implementation
Moderator: Dr Steve Elliott, Amgen
Rapporteur: Mr Marc de Garidel, Chairman, G5 Group
Panelists:
Ms. Barbara Leishman, Head of Safety Science Quality Risk Management, Roche
Ms. Elodie McNeil, Director Regulatory Policy and Intelligence, Abbott
Mr Mark Luttmann, WADA Cooperation Coordinator, GlaxoSmithKline
Representative biotechnology company (tbc)
Dr. Olivier Rabin, Director Science, WADA
Summary: How to build on the work already done and further develop co-operation through an action programme?
General Rapporteurs:
Mr David Howman, WADA
Mr Bruno Genevois, President, Agence française de lutte contre le dopage (AFLD)
Media interested in registering for this event please contact:
Terence O’Rorke
WADA Senior Manager, Media Relations and Communications
E: media@wada-ama.org
T: +1 514 904 8820
Asa service to our readers, Around the Rings will provide verbatim textsof selected press releases issued by Olympic-related organizations,federations, businesses and sponsors.
These press releases appear as sent to Around the Rings and are not edited for spelling, grammar or punctuation.
20 Years at #1:
Últimas Noticias
Sinner-Alcaraz, the duel that came to succeed the three phenomenons
Beyond the final result, Roland Garros left the feeling that the Italian and the Spaniard will shape the great duel that came to help us through the duel for the end of the Federer-Nadal-Djokovic era.
Table tennis: Brazil’s Bruna Costa Alexandre will be Olympic and Paralympic in Paris 2024
She is the third in her sport and the seventh athlete to achieve it in the same edition; in Santiago 2023 she was the first athlete with disabilities to compete at the Pan American level and won a medal.

Rugby 7s: the best player of 2023 would only play the medal match in Paris
Argentinian Rodrigo Isgró received a five-game suspension for an indiscipline in the circuit’s decisive clash that would exclude him until the final or the bronze match; the Federation will seek to make the appeal successful.

Rhonex Kipruto, owner of the world record for the 10000 meters on the road, was suspended for six years
The Kenyan received the maximum sanction for irregularities in his biological passport and the Court considered that he was part of a system of “deliberate and sophisticated doping” to improve his performance. He will lose his record and the bronze medal at the Doha World Cup.

Katie Ledecky spoke about doping Chinese swimmers: “It’s difficult to go to Paris knowing that we’re going to compete with some of these athletes”
The American, a seven-time Olympic champion, referred to the case of the 23 positive controls before the Tokyo Games that were announced a few weeks ago and shook the swimming world. “I think our faith in some of the systems is at an all-time low,” he said.
